About Allergic Rhinitis – Allergic rhinitis (AR) is one of the most common allergic diseases worldwide. In India, AR constitutes about 50%-60% of all the allergic cases. Additionally, patients with AR are frequently associated with exacerbation of symptoms and increased risk of comorbidities. The main goal of AR management is the reduction of symptoms. The treatment choice, however, depends on the efficacy, safety, and affordability of treatment options. Along with pharmacotherapy, adjunctive treatment with nasal saline irrigation has been recommended for sinonasal diseases including allergic rhinitis and rhinosinusitis. It has become an effective tool in improving symptoms in patients with allergic rhinitis. CASE STUDY PROFILE – A 22-year-old college student reported to the ENT clinic with complaints of excessive sneezing, thick nasal discharge, nose blockage, itchy and watery eyes. Diagnosis – The patient was diagnosed with persistent allergic rhinitis. [qsm quiz=3] Treatment – The patient was asked to continue with the prescribed intranasal corticosteroid Given the presence of excessive nasal irritation along with thick nasal discharge and nasal blockage, the patient was suggested to wash nasal passages with isotonic saline solution. The effective cleansing function of isotonic saline would help liquefy thick mucous and improve mucociliary clearance, thereby enhancing mucosal function. Effective mucociliary clearance would ensure the reduction of nasal obstruction and stuffiness. Follow – up – The patient reported significant improvement of allergic symptoms with the regular practice of add-on nasal wash with saline solution. Given the clinical effectiveness of the nasal saline spray, the patient was asked to continue the nasal wash with the saline solution for a month [qsm quiz=4] Discussion – Nasal irrigation using the saline solution is a simple and inexpensive non-pharmacological treatment option in the management of AR. It can be employed as an adjunctive treatment in patients with AR, who are already on…

To continue reading this article ...